A prospective study of the impact upon serum electrolyte and magnesium levels of using magnesium sulfate for bowel preparation for colonoscopy.

Phase 3

Completed

• Conditions: Colonoscopy; Oral and Gastrointestinal - Normal oral and gastrointestinal development and function

• Registration Number: ACTRN12608000160336
• Lead Sponsor: Colocap Pharmaceuticals

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-04-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Presenting for elective colonoscopy.

Exclusion Criteria

Renal insufficiency; current chronic inflammatory bowel disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the difference in serum magnesium, urea, creatinine and electrolytes before and after ingesting 61.75gm dried magnesium sulfate.[PRE: Up to one week prior to taking bowel preparation, and POST: during colonoscopy procedure.]

Secondary Outcome Measures

Name	Time	Method
To assess the efficacy of the preparation using the colonoscopists evaluation of the quality of the bowel clean.[During colonoscopy procedure.];To assess the acceptability of the bowel preparation to patients using their reports of palatability, ease of use and tolerability.[After taking bowel preparation, immediately before procedure.]